Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
Authors
Keywords
Chronic urticaria, Omalizumab, Dermatology life quality index, Urticaria control test
Journal
World Allergy Organization Journal
Volume 14, Issue 1, Pages 100501
Publisher
Elsevier BV
Online
2021-01-10
DOI
10.1016/j.waojou.2020.100501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Addition of omalizumab to antihistamine treatment in chronic urticaria
- (2020) Yu-Di Chen et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial
- (2020) Gordon Sussman et al. Journal of Allergy and Clinical Immunology-In Practice
- Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
- (2019) Nicole Schoepke et al. ALLERGY
- How to treat patients with chronic spontaneous urticaria with omalizumab: Questions and answers
- (2019) Murat Türk et al. Journal of Allergy and Clinical Immunology-In Practice
- Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta‐analysis
- (2019) Julia Fricke et al. ALLERGY
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- (2018) T. Zuberbier et al. ALLERGY
- Omalizumab chronic spontaneous urticaria: efficacy, safety, predictors of treatment outcome and time to response
- (2018) E. Nettis et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria
- (2018) L. Curto-Barredo et al. BRITISH JOURNAL OF DERMATOLOGY
- Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence
- (2018) Jonathan A. Bernstein et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria
- (2018) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
- (2018) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
- (2018) Murat Türk et al. ALLERGOLOGY INTERNATIONAL
- Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria
- (2018) Tessa Niemeyer-van der Kolk et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients
- (2018) A.V. Marzano et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
- (2018) Michael D. Tharp et al. JAMA Dermatology
- Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria
- (2017) Janine Gericke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autoimmune chronic spontaneous urticaria: What we know and what we do not know
- (2017) Pavel Kolkhir et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Management of chronic inducible urticaria according to the guidelines: A prospective controlled study
- (2017) Emek Kocatürk et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Does omalizumab modify a course of recalcitrant chronic spontaneous urticaria?: A retrospective study in Asian patients
- (2017) Kanokvalai Kulthanan et al. JOURNAL OF DERMATOLOGY
- Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
- (2017) Zahava Vadasz et al. Journal of Allergy and Clinical Immunology-In Practice
- Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
- (2016) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of chronic spontaneous urticaria with a single dose of omalizumab: A study of four cases
- (2016) Radhakrishnan Subramaniyan et al. INDIAN JOURNAL OF DERMATOLOGY
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis
- (2014) A. C. Kai et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
- (2014) Karsten Weller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria
- (2014) Martin Metz et al. JAMA Dermatology
- A Long Term Case Series Study of the Effect of Omalizumab on Chronic Spontaneous Urticaria
- (2013) Anna Cecilie Lefévre et al. Annals of Dermatology
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cold Urticaria Patients Exhibit Normal Skin Levels of Functional Mast Cells and Histamine after Tolerance Induction
- (2012) Line Kring Tannert et al. DERMATOLOGY
- Two Cases of Severe Refractory Chronic Idiopathic Urticaria Treated with Omalizumab
- (2010) C Vestergaard et al. ACTA DERMATO-VENEREOLOGICA
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1
- (2010) M. Maurer et al. ALLERGY
- EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticaria
- (2009) G. N. Konstantinou et al. ALLERGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now